21 related articles for article (PubMed ID: 15147952)
1. Transcriptional repressor functions of Drosophila E2F1 and E2F2 cooperate to inhibit genomic DNA synthesis in ovarian follicle cells.
Cayirlioglu P; Ward WO; Silver Key SC; Duronio RJ
Mol Cell Biol; 2003 Mar; 23(6):2123-34. PubMed ID: 12612083
[TBL] [Abstract][Full Text] [Related]
2. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss.
Li FX; Zhu JW; Tessem JS; Beilke J; Varella-Garcia M; Jensen J; Hogan CJ; DeGregori J
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12935-40. PubMed ID: 14566047
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.
Wang D; Xu Q; Yuan Q; Jia M; Niu H; Liu X; Zhang J; Young CY; Yuan H
Oncogene; 2019 May; 38(18):3458-3474. PubMed ID: 30647455
[TBL] [Abstract][Full Text] [Related]
4. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma.
Wittenburg LA; Ptitsyn AA; Thamm DH
J Cell Biochem; 2012 Mar; 113(3):773-83. PubMed ID: 21976144
[TBL] [Abstract][Full Text] [Related]
5. APC/C(Cdc20) targets E2F1 for degradation in prometaphase.
Peart MJ; Poyurovsky MV; Kass EM; Urist M; Verschuren EW; Summers MK; Jackson PK; Prives C
Cell Cycle; 2010 Oct; 9(19):3956-64. PubMed ID: 20948288
[TBL] [Abstract][Full Text] [Related]
6. Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.
Middeldorp J; Kamphuis W; Sluijs JA; Achoui D; Leenaars CH; Feenstra MG; van Tijn P; Fischer DF; Berkers C; Ovaa H; Quinlan RA; Hol EM
FASEB J; 2009 Aug; 23(8):2710-26. PubMed ID: 19332645
[TBL] [Abstract][Full Text] [Related]
7. The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.
Gammoh N; Gardiol D; Massimi P; Banks L
J Virol; 2009 Feb; 83(3):1538-43. PubMed ID: 19004934
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression of E2F gene by proteasome inhibitors in human osteosarcoma cells.
Lim JH; Chang YC; Park YB; Park JW; Kwon TK
Biochem Biophys Res Commun; 2004 Jun; 318(4):868-72. PubMed ID: 15147952
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin.
Magae J; Illenye S; Tejima T; Chang YC; Mitsui Y; Tanaka K; Omura S; Heintz NH
Oncogene; 1997 Aug; 15(7):759-69. PubMed ID: 9266962
[TBL] [Abstract][Full Text] [Related]
10. UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation.
Hsueh CT; Wu YC; Schwartz GK
Clin Cancer Res; 2001 Mar; 7(3):669-74. PubMed ID: 11297263
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
[TBL] [Abstract][Full Text] [Related]
12. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
13. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
Campanero MR; Flemington EK
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
